CX-052075
UNII KFZ2Z65LB6

Substance Identification & Data

This profile provides standardized clinical and technical data for Cx-052075, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KFZ2Z65LB6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3074514-61-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KFZ2Z65LB6

CAS Registry Number

3074514-61-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CX-052075

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

KFZ2Z65LB6

The specific atomic composition represented as a molecular structure string.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cx-052075. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN LP.8.1 VARIANT N-TERMINAL DOMAIN FUSION WITH RECEPTOR-BINDING DOMAIN TRANSGENE PLUS 5'- AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER CX-052075), INNER SALT